Regulatory


Topic Replies Activity
GMP Facility for multiple product 2 February 23, 2018
Indian Regulatory - Suppose unapproved drug in India for marketing & manufacturering 4 February 1, 2018
Regulatory 0 January 28, 2018
Russian Guideline 2 December 26, 2017
Type 1A variation 1 November 21, 2017
Product Development Report 1 November 2, 2017
Claim of the finished prodct 2 November 1, 2017
IT Policy 2017 in Pharma Sector 1 September 25, 2017
Certificate of Analysis in GDP 4 September 1, 2017
COPP /dossier submission 1 August 5, 2017
Pharma HSN COde 1 June 28, 2017
Difference between DMF and 32S 2 June 3, 2017
Packaging cartons 4 June 3, 2017
DMF and Dossier 3 June 3, 2017
Can we manufacure bacteria as well as yeast in same facility 1 June 1, 2017
Discolouration of tablets containing Paracetamol and Codeine Phosphate as APIs 2 April 30, 2017
Celecoxib capsules - biowaiver 1 February 1, 2017
Procedure to obtain Drug License 1 December 16, 2016
Innovator characterization 3 December 14, 2016
Difference between guideline used in pharmaceuticals 2 December 12, 2016
If manufactured have get DCGI permission then manufactured can be export the product without local FDA permission 1 November 29, 2016
Module 3 for multivitamin mineral tablets 1 October 19, 2016
Manufacturing site registration 1 October 12, 2016
List of Forms/ Documents: India 6 September 15, 2016
Regulatory Licensing and Certificate 1 August 6, 2016
Regulatory requirements for Pharmaceutical Rubber Stopper Manufacturer? 2 July 21, 2016
API starting material 4 July 20, 2016
Case study Missbranded drug, Spurious drug 1 July 13, 2016
European union dossier requirements 1 July 11, 2016
Plz give me info abt Domestic RA 2 July 7, 2016